Abstract
Coccinia grandis has been used in tribal populations of India both as food and medicine, but it has been not reported to be a neuroprotective agent yet. The present study was designed to evaluate the protective effects of Coccinia grandis leaf extract on diabetes induced brain damage of Wistar rats. This study reports the protective effect of methanolic leaf extract of Coccinia grandis against STZ induced diabetes in rats. Metformin (150mg/kg body wt.) was used as a reference drug. The enzymes of the polyol pathway and its related substrates were studied in the brain tissue. The effect of Coccinia on Cyclooxygenase (COX) and Prostaglandin peroxidise (PG) was also studied. Diabetes induced rats showed a significantly increased activity of Aldose reductase, Sorbitol dehydrogenase, Glucose-6-phosphodehydrogenase, whereas the decreased activity of Hexokinase. The content of Glucose, Sorbitol significantly increased in rat brain. Sodium potassium ATPase activity was also decreased in diabetic rats. COX, PG peroxidase was increased. Histological alternations were induced in the hippocampus of STZ treated diabetic rats. Oral administration of Coccinia leaf extract (200mg/kg) of body weight to diabetic rats for 21 days efficiently attenuated the parameters studied. A decreased activity of brain AR, sorbitol dehydrogenase, glucose-6-dehydrogenase was observed along with the increase in Hexokinase and Sodium potassium ATPase activity. It also showed decreased content of glucose and Sorbitol. Diabetes induced brain damage in the hippocampus and cerebral cortex was restored with Coccinia treatment. Decreased COX and PG peroxidase suggest its protection against inflammation. The current results suggest that Coccinia grandis leaf extract exerts the potential ability to reverse the progression of hyperglycemia and its concomitant induced brain damage.
Full text article
References
Bancroft, J. D. 2007. Theory and practice of histological techniques. 6th Edition, Elsevier Health Sciences, ISBN: 978-0-443-10279-0.
Baquer, N. Z., Mclean, P., Greenbaum, A. L. 1973. Enzymic differentiation in pathways of carbohydrate metabolism in developing brain. Biochemical and Biophysical Research Communications, 53:1282–1288.
Baynes, J. W. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes, 40:405–412.
Bergmeyer, H. U., Bernt, E., Schmidt, F., Stork, F. 1974. Assay for hexoses. volume 1. In: H.U. Bergmeyer (ed), Methods in Enzymatic Analysis. (Academic Press, New York).
Feschenko, M. S., Donnet, C., Wetzel, R. K., Asinovski, N. K., Jones, L. R., Sweadner, K. J. 2003. Phospholemman, a single-span membrane protein, is an accessory protein of Na+, K+-ATPase in cerebellum and choroid plexus. Journal of Neuroscience, 23(6):2161–2169.
Gabbay, K. H. 1973. The sorbitol pathway and the complication of diabetes. New England Journal of Medicine, 288:831–837.
Gerlach, U. 1983. Oxidoreductases. pages 112–117. In Methods of enzymatic analysis, Verlag Chemie GmbH Weinheim, Germany.
Gumma, K., Mclean, P. 1972. The kinetic quantitation of ATP: D-glucose-6-phosphortransferase. FEBS letters, 27(2):293–297.
Harris, R. A. 2002. International Review of Neurobiology: Glucose Metabolism in the Brain (Glucose, Stress, and Hippocampal Neuronal Vulnerability). volume 51, pages 289–324, Alton, Ill, USA. (Elsevier Science, Alton, Ill, USA).
Hayman, S., Kinoshita, J. H. 1965. Isolation and properties of lens aldose reductase. Journal of Biological Chemistry, 240(2):877–882.
Hunt, J. V., Dean, R. T., Wolff, S. P. 1988. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochemical Journal, 256(1):205–212.
Jang, T. J. 2004. Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis. Virchows Arch, 445:564–71.
Jayanarayanan, S., Smijin, S., Peeyush, K. T., Anju, T. R., Paulose, C. S. 2013. NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin. Chemico-Biological Interactions, 201(1-3):39–48.
Kaplay, S. S. 1978. Erythrocyte membrane Na+K+ATPase activated ATPase in protein calorie malnutrition. Am J Clin Nutri, 31:579.
Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., Isakson, P. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proceedings of the National Academy of Sciences, 93(6):2317–2321.
Low, P. A., Nickander, K. K., Tritschler, H. J. 1997. The role of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes, 46(Suppl 2):38–42.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. 1951. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193:265–275.
Malone, J. I., Knox, G., Benford, S., Tedesco, T. A. 1989. Red cell sorbitol: An indicator of diabetic control. Diabetes, 29(11):861–864.
Mcewen, B. S., Reagan, L. P. 2004. Glucose transporter expression in the central nervous system: relationship to synaptic function. European Journal of Pharmacology, 490(1-3):13–24.
Monnier, V. M. 2003. Intervention against the Maillard reaction in vivo. Archives of Biochemistry and Biophysics, 419(1):1–15.
Nagilla, B., Reddy, K. P. 2014a. Neurogenic inhibition of COX and PG peroxidase with Methanolic leaf extract of Coccinia grandis and amelioration of neuropathic pain in STZ induced diabetic rats. International Journal of Pharmaceutical Science Invention, 3(4):33–40.
Nagilla, B., Reddy, K. P. 2014b. Protective effects of Coccinia grandis leaft extract: Behavioural, Electrophysiological, Biochemical and Histological features of diabetic neuropathy. Int J Pharmaceutical Sciences Res, 5(10):4302–4309.
Pamidi, N., Nayak, B. S. 2012. Effect of streptozotocin induced diabetes on rat hippocampus. Bratisl Lek Listy, 113(10):583–588.
Tan, X., Poulose, E., Raveendran, W. 2011. Regulation of the expression of cyclooxygenases and production of prostaglandin I(2) and E(2) in human coronary artery endothelial cells by curcumin. Journal of Physiology and Pharmacology: an official Journal of the Polish Physiological Society, 62(1):21–28.
Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattari, N., Mizuno, Y. 1998. Protein bound Acrolein: potential markers for oxidative stress. Proceedings of the National Academy of Sciences, 95(9):4882–4887.
Umaheshwari, M., Chatterjee, T. K. 2008. Effect of the Fractions of Coccinia grandis on lipid peroxidation and antioxidants Enzymes in Oxonate-induced Hyperuricaemic Mice. International Journal of Biomedical and Pharmaceutical Sciences, 2(2):108–111.
Vane, J. R., Bakhle, Y. S., Botting, R. M. 1998. Cyclooxygenases 1 and 2. Annual Review of Pharmacology Toxicology, 38:97–120.
Vanegas, H., Schaible, H. G. 2001. Prostaglandins and cyclooxygenases in the spinal cord. Progress in Neurobiology, 64:327–363.
Yamashita, A., Kunimatsu, T., Yamamoto, T., Yoshida, K. 2007. Hypothermic, but not normothermic, ischemia causes a drastic increase in cyclooxygenase-2 immunoreactive granule cells in rat dentate gyrus after 4 hours of ischemic reperfusion. Arch Histol Cytol, 70:197–205.
Zenker, J., Ziegler, D., Chrast, R. 2013. Novel pathogenic pathways in diabetic neuropathy. Trends in Neurosciences, 36(8):439–449.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.